NCT02243111

Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound

Evaluation of Lung Doppler Signals (LDS) in Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc)

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: Echosense Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Doppler signals can be recorded from the lung parenchyma by means of a pulsed Doppler ultrasound system incorporating a special signal processing package; i.e. the transthoracic parametric Doppler (TPD) (EchoSense Ltd., Haifa, Israel). Systemic sclerosis patients often develop pulmonary vascular disease leading to pulmonary hypertension. The TPD system may provide important insight into pulmonary blood vessels characteristics by the LDS signals that are related to pulmonary hypertension. The TPD performance in detecting PAH in SSc patients will be assessed in the study.

Conditions

• Systemic Sclerosis
• Pulmonary Hypertension

Interventions

Type	Name	Description
RADIATION	Doppler ultrasound	Detecting Doppler signals from the lungs on the right chest wall

Timeline

• Start date: 2014-09-01
• Primary completion: 2015-09-01
• Completion: 2015-12-01
• First posted: 2014-09-17
• Last updated: 2016-01-21

Locations

1 site across 1 country: Israel